F. Hoffmann-La Roche Ltd has launched the new Elecsys Anti-Mullerian Hormone, or AMH, blood test, a fertility test for assessing a woman's ovarian reserve. The AMH blood test can be measured during any day of the menstrual cycle and is a superior ... Individual.com, 6 days ago
F. Hoffmann-La Roche Ltd has announced the resignation of Arthur Levinson from the board of directors. Arthur D. Levinson made this decision so as to avoid any conflict of interest given his role as CEO at Calico. "I would like to thank Art for ...Individual.com, 3 weeks ago
Image Credit: 2014 F. Hoffmann-La Roche Ltd Chuck Bednar for redOrbit.com Your Universe Online Perjeta, a new breast cancer drug developed by Swiss pharmaceutical company Roche , has shown unprecedented success in extending the lives of ...Red Orbit, 3 days ago Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis Market Pulse Navigator, 2 weeks ago Global Transcriptomics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and Thermo Fisher Scientific Sys-Con India, 1 week ago Depression Market Analysis - Global API Manufacturers and Phase III Pipeline Assessment, 2014-2015 Individual.com, 2 hours ago
Chugai Pharmaceutical, a subsidiary drug manufacturer operating in Japan controlled by HoffmannLa Roche, has launched the ALK inhibitor Alecensa capsule 20mg and 40mg (alectinib hydrochloride) for the indication of ALK fusion gene positive ...PharmaBiz, 3 weeks ago Chugai Pharmaceutical launches non-small cell lung cancer drug Individual.com, 2 weeks ago
New Clinical Trials and Studies Study Results Reported from F. Hoffmann-La Roche (The use of phase 2 interim analysis to expedite drug development...
New Clinical Trials and Studies Study Results Reported from F. Hoffmann-La Roche (The use of phase 2 interim analysis to expedite drug development decisions) By a News Reporter-Staff News Editor at Clinical Trials Week -- Investigators discuss ...4 Traders, 3 weeks ago Occlusive Arterial Disease Clinical Trials Market 2014 Analysis in a New Report Available at MarketOptimizer.org Wall Street Select, 1 day ago Atherosclerosis Global Clinical Trials Review, H2, 2014 - New Report Available RCL Advisors, 1 week ago
By a News Reporter-Staff News Editor at Biotech Week Hoffmann-La Roche Inc. (Nutley, NJ) has been issued patent number 8829029, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also Pharmaceutical ...Pharmacy Choice, 1 week ago
FEATURED COMPANIES Abbott Laboratories Bayer HealthCare Bioptik Technology F. Hoffmann-La Roche Fudakang Ind'l LifeScan MORE About POCT POCT, also called near-patient ...Research and Markets, 1 week ago Genomics Market in the US 2014-2018 Research and Markets, 1 week ago
FEDERAL COURT OF AUSTRALIA Garford Pty Ltd v Dywidag -Systems International Pty Ltd  FCA 1039 Citation: Garford Pty Ltd v Dywidag -Systems International Pty Ltd  FCA 1039 Parties: GARFORD PTY LTD v DYWIDAG ...Federal Court of Australia, 3 days ago
CHUGAI PHARMACEUTICAL : -Bisphosphonate Antiresorptive Agent, Ibandronate Sodium Hydrate Oral Agent, Demonstrates Efficacy in Osteoporosis in Phase III Trial
Release date- 22092014 - Chugai Pharmaceutical Co., Ltd. [Head Office: Chuo-ku, Tokyo ; Chairman & CEO: Osamu Nagayama (hereafter, 'Chugai')] and Taisho Pharmaceutical Co., Ltd. [Head Office: Toshima-ku, Tokyo ; President: Shigeru Uehara (hereafter, ...4 Traders, 1 week ago CHUGAI PHARMACEUTICAL : Launch of the Anti-Cancer Agent / ALK Inhibitor Alecensa® 4 Traders, 3 weeks ago Chugai Debuts on Dow Jones Sustainability Asia Pacific Index, an Index for Socially Responsible Investment TMC Net, 1 week ago Bisphosphonate antiresorptive agent, ibandronate sodium hydrate oral agent, demonstrates efficacy in osteoporosis in phase III trial PharmaBiz, 1 week ago
Growing Patient Pool and Favorable Regulations Spur the Global Market for Pediatric Drugs and Vaccines, According to New Report by Global Industry Analysts, Inc.
PRWeb Demand for pediatric drugs and vaccines is growing in sync with the increasing birth rate, and the rising incidence and prevalence of various disease and disorders among children across the globe. Historically, the market for pediatric drugs ...Market Pulse Navigator, 1 day ago Surging Diabetic, Obese and Hypertensive Population Drives the Global Cholesterol Testing Market, According to New Report by Global Industry Analysts, Inc. Stock Nod, 1 day ago
on your WebpageAdd Widget >Get your members hooked!